Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 766–780 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-5966 PEX1 Gene Zellweger Syndrome Genetic Test This test analyzes the PEX1 gene for pathogenic variants associated with Zellweger spectrum disorders using Next-Generation Sequencing (NGS). It provides a definitive molecular dia...	Whole Blood (preferred), Extracted DNA, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PEX1 gene sequence variants", "Copy number changes in PEX1 gene"] Parameters [] Preparation ["No specific fasting required", "Avoid sample collection during acute illness"] Indications ["Suspicion of Zellweger spectrum disorder", "Family history of peroxisomal biogenesis disorder", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 93277-8 ICD-10: E71.510 Clinical summary This test analyzes the PEX1 gene for pathogenic variants associated with Zellweger spectrum disorders using Next-Generation Sequencing (NGS). It provides a definitive molecular diagnosis, carrier status, and recurrence risk information.
TEST-5463 PEX11B Gene Peroxisome Biogenesis Disorder 14B Genetic Test This genetic test evaluates the PEX11B gene for pathogenic variants associated with peroxisome biogenesis disorder 14B.	Peripheral whole blood	3–4 weeks (fast-track available)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PEX11B gene sequence", "Pathogenic variants (SNVs, indels, CNVs)"] Parameters [] Preparation ["No specific patient preparation required."] Indications ["Suspected peroxisome biogenesis disorder 14B", "Family history of peroxisomal disorders", "Carrier screening before pregnancy"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: E71.510, Q87.8 Clinical summary This genetic test evaluates the PEX11B gene for pathogenic variants associated with peroxisome biogenesis disorder 14B.
TEST-5886 PEX2 Gene Zellweger Syndrome Genetic Test This genetic test identifies pathogenic variants in the PEX2 gene associated with Zellweger syndrome spectrum disorders.	Peripheral Whole Blood (EDTA) or High-Quality Extracted DNA	3 – 4 Weeks (21 – 28 Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PEX2 gene", "Copy number variations (CNVs) in the PEX2 gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any recent blood transfusions (within 8 weeks)"] Indications ["Suspected Zellweger syndrome spectrum disorder", "Family history of peroxisomal biogenesis disorders", "Prenatal diagnosis", "Carrier screening"] Measurement technique Confirm with laboratory Codes LOINC: 23862-2 ICD-10: E71.510 Clinical summary This genetic test identifies pathogenic variants in the PEX2 gene associated with Zellweger syndrome spectrum disorders.
TEST-5551 PEX3 Gene Peroxisome Biogenesis Disorder Type 10A Genetic Test This genetic test analyzes the PEX3 gene to identify pathogenic variants associated with peroxisome biogenesis disorder type 10A (Zellweger spectrum). It provides a definitive mole...	Peripheral Whole Blood (EDTA) or DNA FTA Card	21–28 Business Days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PEX3 gene", "Single-nucleotide variants", "Insertions", "Deletions", "Copy-number alterations"] Parameters [] Preparation ["No fasting required", "No specific medication or diet restrictions"] Indications ["Clinical suspicion of peroxisome biogenesis disorder type 10A (Zellweger spectrum)", "Family history of peroxisomal disorders", "Confirmation of biochemical findings suggestive of peroxisomal dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 102006-9 ICD-10: E71.518 Clinical summary This genetic test analyzes the PEX3 gene to identify pathogenic variants associated with peroxisome biogenesis disorder type 10A (Zellweger spectrum). It provides a definitive molecular diagnosis for neurodevelopmental and metabolic disorders.
TEST-5555 PEX5 Gene Peroxisome Biogenesis Disorder Type 2A Genetic Test This genetic test identifies pathogenic variants in the PEX5 gene associated with peroxisome biogenesis disorder type 2A.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PEX5 gene", "Single nucleotide variants", "Small indels", "Copy number variations"] Parameters [] Preparation ["Mandatory pre-test genetic counselling session required", "No dietary restrictions for sample collection"] Indications ["Confirmation of clinical diagnosis of PBD-2A", "Guiding management of peroxisomal disorders", "Genetic counseling for families with suspected PBD-2A", "Evaluation of patients with Zellweger spectrum disorders"] Measurement technique Confirm with laboratory Codes LOINC: 21685-0 ICD-10: E71.5 Clinical summary This genetic test identifies pathogenic variants in the PEX5 gene associated with peroxisome biogenesis disorder type 2A.
TEST-5471 PEX5 Gene Peroxisome Biogenesis Disorder Type 2B Genetic Test This genetic test identifies pathogenic variants in the PEX5 gene associated with peroxisome biogenesis disorder type 2B.	Peripheral Whole Blood (3–5 mL in EDTA tube) or Validated DNA Blood Kit	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PEX5 gene", "Full gene coverage"] Parameters [] Preparation ["Complete a documented pre-test genetic counseling session", "Sign an informed consent form", "No fasting required"] Indications ["Suspected peroxisome biogenesis disorder type 2B", "Zellweger spectrum disorder diagnosis", "Patients with neurological, hepatic, and adrenal symptoms consistent with peroxisomal dysfunction"] Measurement technique Confirm with laboratory Codes LOINC: 87809-3 ICD-10: E71.5 Clinical summary This genetic test identifies pathogenic variants in the PEX5 gene associated with peroxisome biogenesis disorder type 2B.
TEST-5889 PEX6 Gene Zellweger Syndrome Genetic Test This genetic test sequences the PEX6 gene to identify pathogenic variants associated with Zellweger spectrum disorders.	Peripheral Whole Blood or FTA Card (Dried Blood Spot)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PEX6 gene sequence", "Pathogenic variants in PEX6"] Parameters [] Preparation ["Do not discontinue prescribed medication without consulting your doctor"] Indications ["Suspected Zellweger spectrum disorder", "Family history of peroxisomal biogenesis disorders", "Need for definitive molecular confirmation"] Measurement technique Confirm with laboratory Codes LOINC: 69548-6 ICD-10: E71.510 Clinical summary This genetic test sequences the PEX6 gene to identify pathogenic variants associated with Zellweger spectrum disorders.
TEST-2890 Pheochromocytoma Profile Test This diagnostic test evaluates for the presence of pheochromocytoma by measuring plasma free metanephrines and 24-hour urine fractionated metanephrines.	Plasma (EDTA) & 24-Hour Urine (acidified)	2 working days	1,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Plasma free metanephrines", "24-hour urine fractionated metanephrines"] Parameters [{"name": "Plasma Free Metanephrines", "reference_range": null}, {"name": "24-Hour Urine Fractionated Metanephrines", "reference_range": null}] Preparation ["Strict 72-hour avoidance of specific medications (alpha-1 blockers, beta-blockers, MAO inhibitors, etc.).", "Avoidance of stimulants (caffeine, nicotine), alcohol, certain foods (chocolate, bananas), and vigorous exercise for 72 hours.", "Continue essential cardiac medications only after explicit approval from your prescribing doctor.", "Fasting is not required, but avoid caffeine and nicotine on the morning of the draw."] Indications ["Suspected pheochromocytoma", "Evaluation of unexplained hypertension", "Family history of pheochromocytoma or related syndromes"] Measurement technique Confirm with laboratory Codes LOINC: 32294-1 ICD-10: D35.00 Clinical summary This diagnostic test evaluates for the presence of pheochromocytoma by measuring plasma free metanephrines and 24-hour urine fractionated metanephrines.
TEST-2994 PHOX2A Gene Central Hypoventilation Syndrome Genetic Test This test identifies pathogenic variants in the PHOX2A gene, which are the primary cause of Congenital Central Hypoventilation Syndrome (CCHS).	Peripheral whole blood	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PHOX2A gene", "Coding exons and splice junctions of the PHOX2A gene"] Parameters [] Preparation ["No specific fasting required", "Inform lab of any medications that might interfere with DNA extraction"] Indications ["Neonates, infants, and children with unexplained hypoventilation", "Infants with cyanotic episodes or apnea", "Family members of confirmed CCHS patients"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: G47.35 Clinical summary This test identifies pathogenic variants in the PHOX2A gene, which are the primary cause of Congenital Central Hypoventilation Syndrome (CCHS).
TEST-4229 PHOX2B Gene Central Hypoventilation Syndrome with or without Hirschsprung Disease Genetic Test This test evaluates the PHOX2B gene for pathogenic variants associated with Congenital Central Hypoventilation Syndrome (CCHS) and Hirschsprung disease.	Whole Blood (EDTA) or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PHOX2B gene variants (SNVs, indels, CNVs)", "Diagnostic sensitivity for CCHS/Hirschsprung disease"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Diagnosis of CCHS", "Diagnosis of Hirschsprung disease", "Pre-symptomatic testing for at-risk family members"] Measurement technique Confirm with laboratory Codes LOINC: 92746-2 ICD-10: G47.35, Q43.1 Clinical summary This test evaluates the PHOX2B gene for pathogenic variants associated with Congenital Central Hypoventilation Syndrome (CCHS) and Hirschsprung disease.
TEST-3946 PHOX2B Gene Sequencing Test This test identifies mutations in the PHOX2B gene, the primary cause of Congenital Central Hypoventilation Syndrome (CCHS). It detects both common and rare variants associated with...	Whole Blood (EDTA), Extracted DNA, or One Drop Blood on FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PHOX2B gene sequence", "Polyalanine repeat length", "Non-PARM sequence variants", "Copy number analysis"] Parameters [] Preparation ["Mandatory genetic counselling session prior to sample collection", "Detailed pedigree chart construction"] Indications ["Suspected Congenital Central Hypoventilation Syndrome (CCHS)", "Evaluation of autonomic respiratory control disorders", "Screening for Hirschsprung disease in CCHS patients", "Family planning for individuals with CCHS"] Measurement technique Confirm with laboratory Codes LOINC: 59099-9 ICD-10: G47.35, Q43.1, Z13.71 Clinical summary This test identifies mutations in the PHOX2B gene, the primary cause of Congenital Central Hypoventilation Syndrome (CCHS). It detects both common and rare variants associated with the disorder.
TEST-4868 PICALM Gene Genetic Test for Immunological & Dermatologic Disorders This test analyzes the PICALM gene for pathogenic variants linked to immunological, dermatologic, and oncological disorders.	Peripheral whole blood	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PICALM gene", "Full coding region and splice sites of PICALM"] Parameters [] Preparation ["No fasting required.", "Provide a three-generation family pedigree.", "Disclose all current medications during genetic counseling."] Indications ["Suspected immunological disorder", "Suspected dermatologic condition", "Cancer predisposition assessment"] Measurement technique Confirm with laboratory Codes LOINC: 21636-6 ICD-10: Z13.89 Clinical summary This test analyzes the PICALM gene for pathogenic variants linked to immunological, dermatologic, and oncological disorders.
TEST-5408 PIEZO2 Gene Distal Arthrogryposis Type 3 (DA3) Genetic Test This test identifies pathogenic variants within the PIEZO2 gene associated with Distal Arthrogryposis Type 3 (Gordon Syndrome). It utilizes full-gene Next-Generation Sequencing for...	Peripheral Whole Blood (EDTA) or FTA Card Dried Blood Spot	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PIEZO2 gene", "Single-nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy-number alterations"] Parameters [{"name": "Analytical Sensitivity", "reference_range": ">99.9% for SNVs, >98% for small indels"}, {"name": "Mean Sequencing Depth", "reference_range": ">30x"}] Preparation ["No specific fasting required", "Inform lab of any medications being taken"] Indications ["Suspected diagnosis of Distal Arthrogryposis Type 3 (Gordon Syndrome)", "Family history of DA3", "Carrier screening", "Prenatal diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 81313-4 ICD-10: Q74.3, Q68.8 Clinical summary This test identifies pathogenic variants within the PIEZO2 gene associated with Distal Arthrogryposis Type 3 (Gordon Syndrome). It utilizes full-gene Next-Generation Sequencing for comprehensive analysis.
TEST-2614 PIEZO2 Gene Marden-Walker Syndrome Genetic Test This test identifies pathogenic variants in the PIEZO2 gene associated with Marden-Walker syndrome.	Peripheral Whole Blood or FTA Card	21 to 28 days	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in PIEZO2 gene coding regions", "Pathogenic variants in PIEZO2 gene splice junctions"] Parameters [] Preparation [] Indications ["Suspected Marden-Walker syndrome", "Family history of Marden-Walker syndrome", "Genetic counseling for recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 94268-2 ICD-10: Q87.0 Clinical summary This test identifies pathogenic variants in the PIEZO2 gene associated with Marden-Walker syndrome.
TEST-2719 PIGW Gene Hyperphosphatasia with Mental Retardation Syndrome Type 5 (HPMRS5) Genetic Test This genetic test identifies pathogenic mutations in the PIGW gene associated with Hyperphosphatasia with Mental Retardation Syndrome Type 5 (HPMRS5). It helps confirm the diagnosi...	Peripheral Whole Blood, Extracted DNA, or FTA Card Sample	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PIGW gene", "Point mutations", "Small indels", "Copy number variants"] Parameters [] Preparation ["No specific fasting required", "No medication or diet changes needed prior to sample collection"] Indications ["Clinical suspicion of Hyperphosphatasia with Mental Retardation Syndrome Type 5 (HPMRS5)", "Confirmation of diagnosis in patients with relevant clinical features"] Measurement technique Confirm with laboratory Codes LOINC: 81263-4 ICD-10: E83.39, Q87.89 Clinical summary This genetic test identifies pathogenic mutations in the PIGW gene associated with Hyperphosphatasia with Mental Retardation Syndrome Type 5 (HPMRS5). It helps confirm the diagnosis in individuals with suggestive clinical features.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories